Key Highlights: Implications: Sanofi’s three-year LOI with Tricog Health gives the AI cardiac diagnostics startup access to Sanofi’s mentorship, market reach, and potential fundi...
Key Highlights: Implications: Optimus Pharma’s DCGI approval for Tapinarof Cream 1% gives India its first locally manufactured, non‑steroidal topical for adult plaque psoriasis, offering dermatologist...
Key Highlights: Implications: The Elephas–Neuberg partnership brings a functional, live‑tissue test for immunotherapy response into India’s mainstream diagnostics, giving oncologists an&nb...
Key Highlights: Implications: Biodeal’s ₹385 crore raise gives it the capital to scale up manufacturing, add new products, and enter more regulated markets, which should help it win bigger, longer-ter...
Key Highlights: Implications: Revahale gives Indian COPD patients—especially older adults and those with severe breathing problems—a simpler, once‑daily nebulized option that doesn’t depend on strong ...
Key Highlights: Implications: By embedding dynamic QR codes and invoice-linked payment links with automatic bill‑by‑bill reconciliation, the solution can materially cut cash handling, spee...
Key Highlights: Implications: The new cGMP/US FDA/EU-compliant suite at Gland’s Visakhapatnam JNPC site, adding ~1,400 kg/year of sterile API capacity, should help both companies capture m...
Key Highlights: Implications: By adding the NSE to its existing BSE listing, Fermenta can attract more institutional and retail participation, which may support tighter spr...
Key Highlights: Implications: By consolidating three injectable-focused entities under one legal umbrella, Aurobindo can streamline manufacturing, R&D, and commercial operati...
Key Highlights: Implications: If completed, the transaction would likely be a strong validation event for mid-sized Indian pharmaceutical businesses that combine branded generics, nu...
